Prodrome Sciences publishes research on the relationship between plasmalogens and the APOE e4 genotype
Our published research shows that a person’s levels of plasmalogens, a critical lipid molecule required for brain and nerve function, is a better indicator of risk of Alzheimer’s disease than the established genetic risk factor APOE e4. This research further emphasizes the need for a plasmalogen blood test to assess risk of Alzheimer’s disease as well as a safe and natural plasmalogen supplement to increase levels of plasmalogens.
Click here to view the publication.
To view a video of Dr. Goodenowe explaining how plasmalogen levels and the APOE genotype affect your risk of dementia click here.